Researchers have been looking at using psilocybin — a chemical compound found in some psychedelic mushrooms — as a treatment for mental health issues, substance use disorders and chronic pain.

An Indiana Senate committee passed a bill that would make it easier for that research to take place in Indiana. SB 139 establishes a fund to give research institutions financial support to study how psilocybin can treat mental health and other medical conditions, but does not legalize the use outside of clinical studies.

Among other things, psilocybin is being studied as a “breakthrough therapy” for post-traumatic stress disorder, treatment-resistant depression and substance use disorders.